251 related articles for article (PubMed ID: 33963726)
1. [Impact of cardiovascular metabolic diseases on COVID-19: review of recent progress].
Han T; Yuan H; Ye L; Jiang X; Bai L; Wang C
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):628-632. PubMed ID: 33963726
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular system is at higher risk of affecting by COVID-19.
Nejadghaderi SA; Heidari A; Shakerian N; Saghazadeh A; Rezaei N
Acta Biomed; 2020 Sep; 91(3):e2020018. PubMed ID: 32921715
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
[TBL] [Abstract][Full Text] [Related]
6. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
Bernard I; Limonta D; Mahal LK; Hobman TC
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far?
Larson AS; Savastano L; Kadirvel R; Kallmes DF; Hassan AE; Brinjikji W
J Am Heart Assoc; 2020 Jul; 9(13):e016793. PubMed ID: 32393136
[TBL] [Abstract][Full Text] [Related]
8. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
[TBL] [Abstract][Full Text] [Related]
10. A close-up on COVID-19 and cardiovascular diseases.
Li G; Hu R; Gu X
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1057-1060. PubMed ID: 32423664
[TBL] [Abstract][Full Text] [Related]
11. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
12. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis.
Zhang Y; He L; Chen H; Lu S; Xiong Y; Liu J; Zheng Y; Wang S; Liu L
Int J Lab Hematol; 2020 Dec; 42(6):766-772. PubMed ID: 32592539
[TBL] [Abstract][Full Text] [Related]
13. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
Chen L; Li X; Chen M; Feng Y; Xiong C
Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
[TBL] [Abstract][Full Text] [Related]
14. [COVID-19 andcardiovascular diseases].
Haeck G; Ancion A; Marechal P; Oury C; Lancellotti P
Rev Med Liege; 2020 Apr; 75(4):226-232. PubMed ID: 32267110
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya.
Ogeng'o J; Karau PB; Misiani M; Cheruiyot I; Olabu B; Kariuki BN
Pan Afr Med J; 2020; 35(Suppl 2):120. PubMed ID: 33282075
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
[TBL] [Abstract][Full Text] [Related]
17. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
Seeherman S; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
[TBL] [Abstract][Full Text] [Related]
18. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
Shi X; Chen M; Zhang Y
Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
[TBL] [Abstract][Full Text] [Related]
19. [Potential therapies for COVID-19 cardiovascular complications using artemisinin and its derivatives intervene based on its cardiovascular protection].
Yang YM; Chen LN; Qu SQ; Deng SQ; Liu H; Wang X; Weng XG; Wang YJ; Zhu XX; Li YJ
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(24):6053-6064. PubMed ID: 33496147
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis?
Xiaoliang Yan ; Jing L; Deng Y
Heart Surg Forum; 2020 Nov; 23(6):E895-E896. PubMed ID: 33253109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
